3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
2
Burkitt Lymphoma
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Multiple Myeloma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Gynecological Solid Tumors
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
65
Rituximab
62
fludarabine
40
Etoposide
25
Lenalidomide
19
fludarabine phosphate
17
Immunotherapy, Adoptive
17
Doxorubicin
17
Cytarabine
17
Vincristine
15
Magnetic Resonance Spectroscopy
14
Prednisone
13
pembrolizumab
11
Specimen Handling
11
Dexamethasone
10
CT-P10
10
Melphalan
9
Carmustine
9
Carboplatin
9
Bortezomib
9
Bendamustine Hydrochloride
9
obinutuzumab
8
ibrutinib
8
Mycophenolic Acid
8
Biopsy
8
Radiotherapy
7
Ifosfamide
7
polatuzumab vedotin
6
Whole-Body Irradiation
6
Methotrexate
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, B-Cell
×
Antibodies, Bispecific
×
Clear all
NCT06796517
2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
72 enrolled